A detailed history of Acadian Asset Management LLC transactions in Novavax Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,602 shares of NVAX stock, worth $30,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,602
Holding current value
$30,508
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.71 - $17.11 $38,577 - $61,630
3,602 New
3,602 $45,000
Q4 2021

Feb 10, 2022

SELL
$134.56 - $217.97 $41,309 - $66,916
-307 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$177.8 - $270.58 $54,584 - $83,068
307 New
307 $63,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.